REVISION THERAPEUTICS

Serial Number 98000952
602

Registration Progress

Application Filed
May 17, 2023
Under Examination
Approved for Publication
Published for Opposition
Registered

Trademark Image

REVISION THERAPEUTICS

Basic Information

Serial Number
98000952
Filing Date
May 17, 2023
Abandonment Date
May 21, 2024
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
602
Status Date
Jun 5, 2024
Classes
005

Rights Holder

ReVision Therapeutics, Inc.

03
Address
251 Little Falls Drive
Wilmington, DE 19808

Ownership History

ReVision Therapeutics, Inc.

Original Applicant
03
Wilmington, DE

Legal Representation

Attorney
Brian O'Donnell

USPTO Deadlines

No Upcoming Deadlines

No upcoming deadlines found for this trademark.

Application History

8 events
Date Code Type Description Documents
Jun 5, 2024 MAB2 E ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND Loading...
Jun 5, 2024 ABN2 O ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE Loading...
Feb 20, 2024 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Feb 20, 2024 GNRT F NON-FINAL ACTION E-MAILED Loading...
Feb 20, 2024 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 9, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
May 23, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
May 20, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceuticals for the treatment of ophthalmic diseases; medicated and non-medicated eye drops; pharmaceutical preparations, serums and injectables for the treatment of retinal or choroidal disease
First Use Anywhere: Dec 21, 2022
First Use in Commerce: Dec 21, 2022

Classification

International Classes
005